Showing results (1011-1020 of 1,030) with videos related to

Sort By:
Pageof 103
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|March 16, 2016
Bevacizumab Plus Irinotecan Versus Temozolomide in Newly Diagnosed O6-Methylguanine-DNA Methyltransferase Nonmethylated Glioblastoma: The Randomized GLARIUS TrialUlrich Herrlinger, Niklas Schäfer, Joachim P Steinbach, et al.
Cancers|July 2, 2021
Toxicity, Response and Survival in Older Patients with Metastatic Melanoma Treated with Checkpoint InhibitorsNienke A de Glas, Esther Bastiaannet, Frederiek van den Bos, et al.
Journal of Geriatric Oncology|May 22, 2021
Outcomes for systemic therapy in older patients with metastatic melanoma: Results from the Dutch Melanoma Treatment RegistryAnouk Jochems, Esther Bastiaannet, Maureen J B Aarts, et al.
European Journal of Cancer (Oxford, England : 1990)|October 5, 2024
Adjuvant immunotherapy in older patients with stage III and resected stage IV melanoma: Toxicity and recurrence-free survival outcomes from the Dutch melanoma treatment registryA Özkan, E Kapiteijn, F van den Bos, et al.
Journal of Medical Genetics|August 19, 2007
Gender-stratified analysis of DLG5 R30Q in 4707 patients with Crohn disease and 4973 controls from 12 Caucasian cohortsB L Browning, V Annese, M L Barclay, et al.
Gastroenterology|August 6, 2016
A Pleiotropic Missense Variant in SLC39A8 Is Associated With Crohn's Disease and Human Gut Microbiome CompositionDalin Li, Jean-Paul Achkar, Talin Haritunians, et al.
Lancet (London, England)|February 21, 2019
Lomustine-temozolomide combination therapy versus standard temozolomide therapy in patients with newly diagnosed glioblastoma with methylated MGMT promoter (CeTeG/NOA-09): a randomised, open-label, phase 3 trialUlrich Herrlinger, Theophilos Tzaridis, Frederic Mack, et al.
Pediatrics|June 29, 2022
Health Impairments in Children and Adolescents After Hospitalization for Acute COVID-19 or MIS-CAline B Maddux, Laura Berbert, Cameron C Young, et al.
European Journal of Cancer (Oxford, England : 1990)|June 5, 2023
Long-term survival with IDH wildtype glioblastoma: first results from the ETERNITY Brain Tumor Funders' Collaborative Consortium (EORTC 1419)Caroline Hertler, Jörg Felsberg, Dorothee Gramatzki, et al.
Nature Communications|August 10, 2024
A real-world observation of patients with glioblastoma treated with a personalized peptide vaccinePauline Latzer, Henning Zelba, Florian Battke, et al.
Pageof 103